Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8958 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8784 |
High Similarity |
NPD6799 |
Approved |
0.871 |
High Similarity |
NPD7075 |
Discontinued |
0.8636 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD7819 |
Suspended |
0.86 |
High Similarity |
NPD2532 |
Approved |
0.86 |
High Similarity |
NPD2534 |
Approved |
0.86 |
High Similarity |
NPD2533 |
Approved |
0.8571 |
High Similarity |
NPD6801 |
Discontinued |
0.8562 |
High Similarity |
NPD6599 |
Discontinued |
0.8526 |
High Similarity |
NPD3882 |
Suspended |
0.8462 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8442 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8367 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8366 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8355 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8344 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8322 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8301 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8272 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8272 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8255 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8231 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8212 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8188 |
Intermediate Similarity |
NPD2796 |
Approved |
0.817 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8165 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8163 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8153 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8148 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8144 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8084 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8067 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8067 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8012 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8012 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7964 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7959 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD3748 |
Approved |
0.787 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD919 |
Approved |
0.7818 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7818 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7801 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7792 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7738 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD943 |
Approved |
0.7716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7688 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7682 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7677 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7677 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7673 |
Intermediate Similarity |
NPD920 |
Approved |
0.766 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7628 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7605 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD411 |
Approved |
0.7584 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7562 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7543 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7541 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7471 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7471 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7458 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7439 |
Intermediate Similarity |
NPD37 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7425 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD4965 |
Approved |
0.741 |
Intermediate Similarity |
NPD4966 |
Approved |
0.741 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7386 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7372 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7372 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7372 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3764 |
Approved |
0.734 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7314 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7302 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7302 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD9268 |
Approved |
0.726 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7258 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD3268 |
Approved |
0.725 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7225 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7215 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7198 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7172 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7152 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7151 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7128 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7124 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7107
|
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |